nimustine has been researched along with Abnormalities, Autosome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukaya, R; Hirose, Y; Ikeda, E; Kawase, T; Takahashi, S | 1 |
| Natsume, S; Satake, T; Shimokawa, T; Takeyama, H; Watanabe, E; Yamada, H | 1 |
| Amemiya, Y; Hatake, K; Miura, Y; Miyata, T; Muroi, K; Saito, M | 1 |
3 other study(ies) available for nimustine and Abnormalities, Autosome
| Article | Year |
|---|---|
Chromosome arm 1q gain associated with good response to chemotherapy in a malignant glioma. Case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chromosome Aberrations; Chromosomes, Human, Pair 1; Glioblastoma; Humans; Male; Nimustine; Peplomycin; Treatment Outcome; Vincristine | 2007 |
[A case of essential thrombocythemia with clonal evolution in the terminal phase].
Topics: Aneuploidy; Cerebral Infarction; Chromosome Aberrations; Drug Therapy, Combination; Humans; Interferon-alpha; Male; Middle Aged; Mitobronitol; Myocardial Infarction; Nimustine; Thrombocytosis | 1994 |
Therapy-related chronic myelomonocytic leukaemia with bone marrow eosinophilia associated with der(11)t(1;11)(q21;q14).
Topics: Antineoplastic Agents; Bone Marrow; Brain Neoplasms; Child; Chromosome Aberrations; Eosinophilia; Fatal Outcome; Glioma; Humans; Hydroxyurea; Karyotyping; Leukemia, Myelomonocytic, Chronic; Leukocyte Count; Lymphocyte Activation; Male; Nimustine | 1996 |